Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG

Deborah T. Blumenthal; Thierry Gorlia; Mark R. Gilbert; Michelle M. Kim; L. Burt Nabors; Warren P. Mason; Monika E. Hegi; Peixin Zhang; Vassilis Golfinopoulos; James R. Perry; Hyun Nam; Sara C. Erridge; Benjamin W. Corn; René O Mirimanoff; Paul D. Brown; Brigitta G. Baumert; Minesh P. Mehta; Martin J. van den Bent; David A. Reardon; Michael Weller; Roger Stupp

doi:10.1093/neuonc/nox025

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG

Deborah T. Blumenthal, Thierry Gorlia, Mark R. Gilbert, Michelle M. Kim, L. Burt Nabors, Warren P. Mason, Monika E. Hegi, Peixin Zhang, Vassilis Golfinopoulos, James R. Perry, Hyun Nam, Sara C. Erridge, Benjamin W. Corn, René O Mirimanoff, Paul D. Brown, Brigitta G. Baumert, Minesh P. Mehta, Martin J. van den Bent, David A. Reardon, Michael WellerRoger Stupp

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	19
DOIs	https://doi.org/10.1093/neuonc/nox025
State	Published - Jan 11 2015

Disciplines

Medicine and Health Sciences
Pathology
Immunology and Infectious Disease

Access to Document

10.1093/neuonc/nox025License: Unspecified

Cite this

Blumenthal, D. T., Gorlia, T., Gilbert, M. R., Kim, M. M., Nabors, L. B., Mason, W. P., Hegi, M. E., Zhang, P., Golfinopoulos, V., Perry, J. R., Nam, H., Erridge, S. C., Corn, B. W., Mirimanoff, R. O., Brown, P. D., Baumert, B. G., Mehta, M. P., van den Bent, M. J., Reardon, D. A., ... Stupp, R. (2015). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-oncology, 19. https://doi.org/10.1093/neuonc/nox025

Blumenthal, DT, Gorlia, T, Gilbert, MR, Kim, MM, Nabors, LB, Mason, WP, Hegi, ME, Zhang, P, Golfinopoulos, V, Perry, JR, Nam, H, Erridge, SC, Corn, BW, Mirimanoff, RO, Brown, PD, Baumert, BG, Mehta, MP, van den Bent, MJ, Reardon, DA, Weller, M & Stupp, R 2015, 'Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG', Neuro-oncology, vol. 19. https://doi.org/10.1093/neuonc/nox025

@article{f9bb4e515d7244bc97dc31e596be98d2,

title = "Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG",

author = "Blumenthal, \{Deborah T.\} and Thierry Gorlia and Gilbert, \{Mark R.\} and Kim, \{Michelle M.\} and Nabors, \{L. Burt\} and Mason, \{Warren P.\} and Hegi, \{Monika E.\} and Peixin Zhang and Vassilis Golfinopoulos and Perry, \{James R.\} and Hyun Nam and Erridge, \{Sara C.\} and Corn, \{Benjamin W.\} and Mirimanoff, \{Ren{\'e} O\} and Brown, \{Paul D.\} and Baumert, \{Brigitta G.\} and Mehta, \{Minesh P.\} and \{van den Bent\}, \{Martin J.\} and Reardon, \{David A.\} and Michael Weller and Roger Stupp",

note = "Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2015.BACKGROUND: Following maximal safe resection, radiation (RT) with concurrent and 6 cycles (C) of adjuvant temozolomide (TMZ) [Stupp NEJM 2005] has been established as standard of care for newly-diagnosed glioblastoma (GBM). This regimen has been adopted with variations, including extending TMZ beyond 6 cycles.",

year = "2015",

month = jan,

day = "11",

doi = "10.1093/neuonc/nox025",

language = "American English",

volume = "19",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG

AU - Blumenthal, Deborah T.

AU - Gorlia, Thierry

AU - Gilbert, Mark R.

AU - Kim, Michelle M.

AU - Nabors, L. Burt

AU - Mason, Warren P.

AU - Hegi, Monika E.

AU - Zhang, Peixin

AU - Golfinopoulos, Vassilis

AU - Perry, James R.

AU - Nam, Hyun

AU - Erridge, Sara C.

AU - Corn, Benjamin W.

AU - Mirimanoff, René O

AU - Brown, Paul D.

AU - Baumert, Brigitta G.

AU - Mehta, Minesh P.

AU - van den Bent, Martin J.

AU - Reardon, David A.

AU - Weller, Michael

AU - Stupp, Roger

N1 - Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2015.BACKGROUND: Following maximal safe resection, radiation (RT) with concurrent and 6 cycles (C) of adjuvant temozolomide (TMZ) [Stupp NEJM 2005] has been established as standard of care for newly-diagnosed glioblastoma (GBM). This regimen has been adopted with variations, including extending TMZ beyond 6 cycles.

PY - 2015/1/11

Y1 - 2015/1/11

UR - https://academic.oup.com/neuro-oncology/article/17/suppl_5/v2/2765390/ATCT-08THE-IMPACT-OF-EXTENDED-ADJUVANT

U2 - 10.1093/neuonc/nox025

DO - 10.1093/neuonc/nox025

M3 - Article

VL - 19

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG

Disciplines

Access to Document

Other files and links

Cite this